Atlas of Cancer Signaling Network: A Resource of Multi-Scale Biological Maps to Study Disease Mechanisms
暂无分享,去创建一个
E. Barillot | A. Zinovyev | I. Kuperstein | M. Kondratova | C. Lonjou | J. Ravel | Nicolas Sompairac | N. Sompairac | Luis Cristobal Monraz Gomez | L. C. M. Gomez
[1] Inna Kuperstein,et al. Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer. , 2018, Cancer cell.
[2] Ryan Miller,et al. WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research , 2017, Nucleic Acids Res..
[3] T Avril,et al. Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers , 2017, Oncogenesis.
[4] Alfonso Valencia,et al. A molecular hypothesis to explain direct and inverse co-morbidities between Alzheimer’s Disease, Glioblastoma and Lung cancer , 2017, Scientific Reports.
[5] Chiara Riganti,et al. PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy , 2017, Molecular Cancer.
[6] Elisabeth Cardis,et al. Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiation , 2017, BMC Cancer.
[7] Nils Blüthgen,et al. Classification of gene signatures for their information value and functional redundancy , 2017, npj Systems Biology and Applications.
[8] José Lages,et al. Inferring hidden causal relations between pathway members using reduced Google matrix of directed biological networks , 2017, bioRxiv.
[9] Inna Kuperstein,et al. NaviCom: a web application to create interactive molecular network portraits using multi-level omics data , 2016, bioRxiv.
[10] Piotr Gawron,et al. MINERVA—a platform for visualization and curation of molecular interaction networks , 2016, npj Systems Biology and Applications.
[11] Y. Pommier,et al. Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors , 2016, Clinical Cancer Research.
[12] Anaïs Baudot,et al. Editorial: Direct and Inverse Comorbidities Between Complex Disorders , 2016, Front. Physiol..
[13] E. Barillot,et al. ROMA: Representation and Quantification of Module Activity from Target Expression Data , 2016, Front. Genet..
[14] J. Mesirov,et al. The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .
[15] Dhruv Chauhan,et al. A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation* , 2015, The Journal of Biological Chemistry.
[16] Jing Chen,et al. NDEx, the Network Data Exchange. , 2015, Cell systems.
[17] Antonio Facchiano,et al. Cancer Microenvironment and Endoplasmic Reticulum Stress Response , 2015, Mediators of inflammation.
[18] Inna Kuperstein,et al. Network-based approaches for drug response prediction and targeted therapy development in cancer. , 2015, Biochemical and biophysical research communications.
[19] E. Barillot,et al. Atlas of Cancer Signalling Network: a systems biology resource for integrative analysis of cancer data with Google Maps , 2015, Oncogenesis.
[20] A. Zinovyev,et al. Network biology elucidates metastatic colon cancer mechanisms , 2015, Cell cycle.
[21] Inna Kuperstein,et al. NaviCell Web Service for network-based data visualization , 2015, Nucleic Acids Res..
[22] B. Hyman,et al. Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation , 2015, Cell Death and Differentiation.
[23] E. Barillot,et al. The shortest path is not the one you know: application of biological network resources in precision oncology research. , 2015, Mutagenesis.
[24] Ram Rup Sarkar,et al. Comparison of human cell signaling pathway databases—evolution, drawbacks and challenges , 2015, Database J. Biol. Databases Curation.
[25] Emmanuel Barillot,et al. DeDaL: Cytoscape 3.0 app for producing and morphing data-driven and structure-driven network layouts , 2015, bioRxiv.
[26] Alan Ashworth,et al. Synthetic lethality and cancer therapy: lessons learned from the development of PARP inhibitors. , 2015, Annual review of medicine.
[27] Inna Kuperstein,et al. Concomitant Notch activation and p53 deletion trigger epithelial-to-mesenchymal transition and metastasis in mouse gut , 2014, Nature Communications.
[28] Tao Zeng,et al. Prediction of dynamical drug sensitivity and resistance by module network rewiring-analysis based on transcriptional profiling. , 2014, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[29] Lei Huang,et al. DrugComboRanker: drug combination discovery based on target network analysis , 2014, Bioinform..
[30] H. Kitano,et al. Toward an integrated software platform for systems pharmacology , 2013, Biopharmaceutics & drug disposition.
[31] Laurence Calzone,et al. Correction: Integrative Modelling of the Influence of MAPK Network on Cancer Cell Fate Decision , 2013, PLoS Computational Biology.
[32] Ney Lemke,et al. Prediction of Oncogenic Interactions and Cancer-Related Signaling Networks Based on Network Topology , 2013, PloS one.
[33] Samik Ghosh,et al. A comprehensive map of the influenza A virus replication cycle , 2013, BMC Systems Biology.
[34] Ioannis Xenarios,et al. Efficient computation of minimal perturbation sets in gene regulatory networks , 2013, Front. Physiol..
[35] Carlo Caltagirone,et al. Inverse occurrence of cancer and Alzheimer disease , 2013, Neurology.
[36] Samik Ghosh,et al. Integrating Pathways of Parkinson's Disease in a Molecular Interaction Map , 2013, Molecular Neurobiology.
[37] E. Barillot,et al. OCSANA: optimal combinations of interventions from network analysis , 2013, Bioinform..
[38] Ronan M. T. Fleming,et al. A community-driven global reconstruction of human metabolism , 2013, Nature Biotechnology.
[39] Emmanuel Barillot,et al. BiNoM 2.0, a Cytoscape plugin for accessing and analyzing pathways using standard systems biology formats , 2013, BMC Systems Biology.
[40] Inna Kuperstein,et al. NaviCell: a web-based environment for navigation, curation and maintenance of large molecular interaction maps , 2013, BMC Systems Biology.
[41] Tzeng-Ji Chen,et al. Does Alzheimer’s Disease Protect against Cancers? A Nationwide Population-Based Study , 2012, Neuroepidemiology.
[42] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[43] Isaac Crespo,et al. A Novel Network Integrating a miRNA-203/SNAI1 Feedback Loop which Regulates Epithelial to Mesenchymal Transition , 2012, PloS one.
[44] A. Menssen,et al. miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions , 2011, Cell cycle.
[45] M. Nieto,et al. The ins and outs of the epithelial to mesenchymal transition in health and disease. , 2011, Annual review of cell and developmental biology.
[46] Robert Gentleman,et al. An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription , 2011, Nucleic acids research.
[47] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[48] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[49] Gary D. Bader,et al. Pathway Commons, a web resource for biological pathway data , 2010, Nucleic Acids Res..
[50] C. Ching,et al. Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway , 2010, Laboratory Investigation.
[51] H Snowden,et al. AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K , 2010, Oncogene.
[52] Umar Mahmood,et al. Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment , 2010, Proceedings of the National Academy of Sciences.
[53] Samik Ghosh,et al. Erratum: The Systems Biology Graphical Notation , 2009, Nature Biotechnology.
[54] A. Grossman,et al. Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis , 2009, Expert opinion on therapeutic targets.
[55] Nina M. Muñoz,et al. TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway. , 2009, Gastroenterology.
[56] S. Artavanis-Tsakonas,et al. Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine , 2009, Proceedings of the National Academy of Sciences.
[57] Jean-Luc Coll,et al. Small-Molecule Drugs Mimicking DNA Damage: A New Strategy for Sensitizing Tumors to Radiotherapy , 2009, Clinical Cancer Research.
[58] Emmanuel Barillot,et al. BiNoM: a Cytoscape plugin for manipulating and analyzing biological networks , 2008, Bioinform..
[59] O. Delattre,et al. Mesenchymal stem cell features of Ewing tumors. , 2007, Cancer cell.
[60] J. Mesirov,et al. From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005 .
[61] Yukiko Matsuoka,et al. Using process diagrams for the graphical representation of biological networks , 2005, Nature Biotechnology.
[62] Hiroaki Kitano,et al. CellDesigner: a process diagram editor for gene-regulatory and biochemical networks , 2003 .
[63] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.